Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Gaebel, Ralf ^a   Furlani, Dario ^a   Sorg, Heiko ^a   Polchow, Bianca ^a   Frank, Johannes ^a   Bieback, Karen ^b   Wang, Weiwei ^a   Klopsch, Christian ^a   Ong, Lee Lee ^a   Li, Wenzhong ^a   Ma, Nan ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Institute of Transfusion Medicine and Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; CD150 ANTIGEN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN;

ACIDIFICATION; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CAPILLARY DENSITY; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN FUNCTION; THERAPY EFFECT; TISSUE REGENERATION; UMBILICAL CORD BLOOD; ANGIOGENESIS; ANIMAL; CAPILLARY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; HEART; LIGATION; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; WOUND HEALING;

ANIMALIA; MUS;

ANIMALS; ANTIGENS, CD; CAPILLARIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HEART; HUMANS; LIGATION; MALE; MESENCHYMAL STEM CELLS; MICE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CELL SURFACE; REGENERATION; WOUND HEALING;

EID: 79951828032     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015652     Document Type: Article

References (61)

1. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD, (1996) Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: 2512-2523.
2. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933.
3. Jia ZQ, Mickle DA, Weisel RD, Mohabeer MK, Merante F, et al. (1997) Transplanted cardiomyocytes survive in scar tissue and improve heart function. Transplant Proc 29: 2093-2094.
4. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, et al. (1996) Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62: 654-660; discussion 660-651.
5. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA, (1999) Smooth muscle cell transplantation into myocardial scar tissue improves heart function. Journal of Molecular and Cellular Cardiology 31: 513-522.
6. Yoo KJ, Li RK, Weisel RD, Mickle DA, Li G, et al. (2000) Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 70: 859-865.
7. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, et al. (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-256.
8. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
9. Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ, (2001) Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 72: 1957-1963.
10. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
11. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083.
12. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017.
13. Ma N, Ladilov Y, Moebius JM, Ong L, Piechaczek C, et al. (2006) Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells. Cardiovasc Res 71: 158-169.
14. Pittenger MF, Martin BJ, (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20.
15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
16. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
17. Nesselmann C, Li W, Ma N, Steinhoff G, (2010) Stem cell-mediated neovascularization in heart repair. Ther Adv Cardiovasc Dis 4: 27-42.
18. Wang W, Li W, Ou L, Flick E, Mark P, et al. (2010) Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J Cell Mol Med.
19. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, et al. (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354: 700-706.
20. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE, (1999) Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 17: 171-177.
21. Mueller SM, Glowacki J, (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82: 583-590.
22. Stenderup K, Justesen J, Clausen C, Kassem M, (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
23. Bieback K, Kern S, Kluter H, Eichler H, (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634.
24. Erices A, Conget P, Minguell JJ, (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
25. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, et al. (2001) Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7: 581-588.
26. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, et al. (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
27. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, et al. (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200: 123-135.
28. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
29. Wagner W, Bork S, Horn P, Krunic D, Walenda T, et al. (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4: e5846.
30. Bork S, Pfister S, Witt H, Horn P, Korn B, et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
31. Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, et al. Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica 95: 867-874.
32. Wagner W, Ho AD, Zenke M, Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16: 445-453.
33. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, et al. (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
34. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
35. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, et al. (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: 2118-2127.
36. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
37. Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, et al. (2003) Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 5: 224-230.
38. Barry F, Boynton RE, Liu B, Murphy JM, (2001) Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268: 189-200.
39. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, et al. (2005) Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673.
40. Bieback K, Kern S, Kocaomer A, Ferlik K, Bugert P, (2008) Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 18: S71-76.
41. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, et al. (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233: 901-913.
42. Ma N, Stamm C, Kaminski A, Li W, Kleine HD, et al. (2005) Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 66: 45-54.
43. Duff SE, Li C, Garland JM, Kumar S, (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17: 984-992.
44. Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D, Vary CP, et al. (2004) Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 279: 32858-32868.
45. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, et al. (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1: 1623-1634.
46. Wikstrom P, Lissbrant IF, Stattin P, Egevad L, Bergh A, (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51: 268-275.
47. van de Kerkhof PC, Rulo HF, van Pelt JP, van Vlijmen-Willems IM, De Jong EM, (1998) Expression of endoglin in the transition between psoriatic uninvolved and involved skin. Acta Derm Venereol 78: 19-21.
48. Wang B, Hao J, Jones SC, Yee MS, Roth JC, et al. (2002) Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am J Physiol Heart Circ Physiol 282: H1685-1696.
49. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, et al. (1999) Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31: 667-678.
50. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, et al. (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116: 2677-2685.
51. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, et al. (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J 14: 55-64.
52. Penn MS, Mangi AA, (2008) Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res 102: 1471-1482.
53. Wang X, Zhao T, Huang W, Wang T, Qian J, et al. (2009) Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells 27: 3021-3031.
54. Li WZ, Nesselmann C, Zhou ZH, Ong LL, Ori F, et al. (2007) Gene delivery to the heart by magnetic nanobeads. Journal of Magnetism and Magnetic Materials 311: 336-341.
55. Li W, Ma N, Ong LL, Kaminski A, Skrabal C, et al. (2008) Enhanced thoracic gene delivery by magnetic nanobead-mediated vector. J Gene Med 10: 897-909.
56. Wang W, Li W, Ong LL, Lutzow K, Lendlein A, et al. (2009) Localized and sustained SDF-1 gene release mediated by fibronectin films: A potential method for recruiting stem cells. Int J Artif Organs 32: 141-149.
57. Wang W, Li W, Ong LL, Furlani D, Kaminski A, et al. (2010) Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing. J Cell Mol Med 14: 392-402.
58. Ong LL, Li W, Oldigs JK, Kaminski A, Gerstmayer B, et al. (2010) Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells. Tissue Eng Part C Methods 16: 1069-1081.
59. Ou L, Li W, Zhang Y, Wang W, Liu J, et al. (2010) Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model J Cell Mol Med PMID: 20477905.
60. Thedinga E, Kob A, Holst H, Keuer A, Drechsler S, et al. (2007) Online monitoring of cell metabolism for studying pharmacodynamic effects. Toxicol Appl Pharmacol 220: 33-44.
61. Furlani D, Li W, Pittermann E, Klopsch C, Wang L, et al. (2009) A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant 18: 319-331.